Zepbound® Vial
US$ 24.67
glp 1 perimenopause And GLP-1 Weight Loss Injections: Understanding Semaglutide & Tirzepatide Are you navigating menopause while
Description
[PubMed ID: 18383954]
GLP-1 receptor agonists are already well established for their role in glycemic control and cardiovascular risk reduction
The mechanisms could include reduced inflammation, improved metabolic health, direct effects on brain reward pathways, or the psychological benefit of successful weight management
The editorial suggests that it may help to think of GLP-1 drugs like other medications for chronic conditions
Also, in elderly diabetic patients with obesity, semaglutide therapy led to a moderate but clinically relevant reduction in BW and BMI after 3 months
